HYPR - hyperfine.io Operating income before deduction of amortization

Graphic logo of hyperfine.io (HYPR)

Hyperfine, Inc. (HYPR) generates revenue through the supply of mobile MRI systems, creating long-term clinic dependency on paid services and software. The EBITDA volume illustrates financial stability, where the parameter mark equals 0.00. Management is focused on cost reduction alongside the transparent implementation of innovations, while automated component assembly and cloud-based AI analysis accelerate business scaling.

HYPR Hyperfine Medical Operating profit before deduction of amortization (11/23/2025 - 11/10/2026)

Hyperfine (HYPR) - metric breakdowns and financial figures

- current price and projected stock value:
Price Hyperfine Medical|HYPR - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Hyperfine|HYPR - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Hyperfine|HYPR - Company Net Assets|Market Value to Book Value hyperfine.io|HYPR - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Hyperfine, Inc.|HYPR - Long-Term Debt to Capital|Current Liabilities to Capital Hyperfine Inc|HYPR - Company Aggregate Debts|Debt to Book Value Ratio Hyperfine|HYPR - Company Long-Term Debts|Short-Term Debt Volume Hyperfine|Quick Liquidity Indicator hyperfine.io
- earnings and multiples data:
HYPR - Net Profit|Projected Future Earnings Hyperfine, Inc.|HYPR - Price to Earnings Ratio|Future Price to Earnings hyperfine.io|HYPR - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Hyperfine|HYPR - Operating profit EBITDA|Net earnings per one share for the last twelve months Hyperfine|HYPR - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year hyperfine.io|HYPR - Net earnings per share growth this year|Earnings growth forecast for next year Hyperfine, Inc.
Summary company analytics:Hyperfine Medical - HYPR
Mass-produced product of Hyperfine, Inc.

This metric determines the investment stability of Hyperfine, Inc. by measuring real cash flow from core operations excluding depreciation and tax adjustments. By analyzing the EBITDA chart, an investor can see the actual ability of the portable MRI developer to generate profit, which, combined with basic compliance with eco-standards during system assembly, confirms the operational viability of the business model.

Who Hyperfine, Inc. competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azenta, Inc. (AZTA)|Operating profit before deduction of amortization vareximaging.com VREX|Operating profit EBITDA SMLR (Semler Scientific)|Butterfly Network Inc (BFLY) - Profit before interest, taxes and amortization|Mesa Labs Corp - Operating profit EBITDA|QSI (Quantum-Si Corporation) - Operating profit before amortization|NNOX: Operating profit EBITDA|QTRX - Operating income before deduction of amortization|MASS (908 Devices) - Operating profit EBITDA|Operating profit before deduction of amortization CapsoVision Medical (CV)|Operating profit EBITDA MXCT|Operating profit EBITDA rapidmicrobio.com (RPID)|Profit before payment of interest, taxes and amortization Seer, Inc. SEER|fonar.com - Profit before payment of interest, taxes and amortization|DXR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization MDAI (spectral-ai.com)|VIVS: Operating profit EBITDA|Profit before interest, taxes and amortization Aclarion Corporation (ACON)|Profit before payment of interest, taxes and amortization Akoya Biosciences Inc|THMO - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)